MediFind found 5 doctor with experience in Beta-Propeller Protein-Associated Neurodegeneration near Chicago, IL. Of these, 4 are Experienced and 1 are Advanced.
Dimitri Krainc is a Neurologist in Chicago, Illinois. Dr. Krainc has been practicing medicine for over 33 years and is rated as an Advanced provider by MediFind in the treatment of Beta-Propeller Protein-Associated Neurodegeneration. His top areas of expertise are Movement Disorders, Parkinson's Disease, Farber Lipogranulomatosis, Early Infantile Epileptic Encephalopathy, and Deep Brain Stimulation.
Ignacio Keller is a Neurologist in Chicago, Illinois. Dr. Keller has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Beta-Propeller Protein-Associated Neurodegeneration. His top areas of expertise are Spinocerebellar Ataxia Type 27, Drug Induced Dyskinesia, Focal Dystonia, Movement Disorders, and Deep Brain Stimulation.
Niccolo Mencacci is a Neurologist in Chicago, Illinois. Dr. Mencacci has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Beta-Propeller Protein-Associated Neurodegeneration. His top areas of expertise are Chorea, Drug Induced Dyskinesia, Movement Disorders, Myoclonus-Dystonia, and Deep Brain Stimulation.
Rush University Medical Group
Brandon Barton is a Neurologist in Chicago, Illinois. Dr. Barton is rated as an Experienced provider by MediFind in the treatment of Beta-Propeller Protein-Associated Neurodegeneration. His top areas of expertise are Movement Disorders, Parkinson's Disease, Primary Familial Brain Calcification, Secondary Parkinsonism, and Deep Brain Stimulation. Dr. Barton is currently accepting new patients.
Erin Kim is a Neurologist in Chicago, Illinois. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Beta-Propeller Protein-Associated Neurodegeneration. Her top areas of expertise are Juvenile Dermatomyositis, Dermatomyositis, Polymyositis, and Myositis.
Last Updated: 10/30/2025


